A new possible lung cancer marker: VGF detection from the conditioned medium of pulmonary large cell neuroendocrine carcinoma-derived cells using secretome analysis

International Journal of Biological Markers

Volumn 24, Issue 4, 2009, Pages 282-285

  Matsumoto, Toshihide ^a   Kawashima, Yusuke ^a   Nagashio, Ryo ^a,b   Kageyama, Taihei ^a   Kodera, Yoshio ^a   Jiang, Shi Xu ^a   Okayasu, Isao ^a   Kameya, Toru ^c   Sato, Yuichi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c SHIZUOKA CANCER CENTER   (Japan)

Author keywords

LCNEC; SCLC; Secretome; VGF mRNA; VGF peptide

Indexed keywords

LIPOCALIN 1; MESSENGER RNA; NERVE GROWTH FACTOR; PEPTIDE VGF; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MARKER; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LUNG LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG SMALL CELL CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROENDOCRINE TUMOR; PEPTIDE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 76649105782     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.2661     Document Type: Article

References (20)

1. Travis WD, Linnila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991; 15: 529-53.
2. Travis WD, Colby TV, Corrin B, Harris CC. World Health Organization international histological classification of tumours. Histological typing of lung and pleural tumours, 3rd ed. Berlin, Heidelberg, New York: Springer Verlag, 1991.
3. Marchevsky AM, Gal AA, Shah S, Koss MN. Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol 2001; 116: 466-72.
4. Jiang SX, Kameya T, Asamura H, et al. hASH-1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 2004; 17: 222-9.
5. Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006; 116: 271-84.
6. Petricoin EF 3rd, Ornstein DK, Paweltz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94: 1576-8.
7. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-67.
8. Rogers MA, Clarke P, Noble J, et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res 2003; 63: 6971-83.
9. Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S, Sauter ER. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 2004; 10: 7500-10.
10. de Bont JM, den Boer ML, Reddingius RE, et al. Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling. Clin Chem 2006; 52: 1501-9.
11. van den Bemd GC, Krijgsveld J, Luider TM, van Rijswijk AL, Demmers JA, Jenster G. Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice. Mol Cell Proteomics 2006; 5: 1830-9.
12. Sardana G, Jung K, Stephan C, Diamandis EP. Proteomics analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: Discovery and validation of candidate prostate cancer biomarkers. J Proteome Res 2008; 7: 3329-38.
13. Volmer MW, Stuhler K, Zapatka M, et al. Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics 2005; 5: 2587-601.
14. Canu N, Possenti R, Ricco AS, Rocchi M, Levi A. Cloning, structural organization analysis, and chromosomal assignment of the human gene for the neurosecretory protein VGF. Genomics 1997; 45: 443-6.
15. Feldman SA, Eiden LE. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocr Pathol 2003; 14: 3-23.
16. Ferri GL, Possenti R. vgf A neurotrophin-inducible gene expressed in neuroendocrine tissues. Trends Endocrinol Metab 1996; 7: 233-9.
17. Snyder SE, Cheng HW, Murray KD, Isackson PJ, McNeill TH, Salton SR. The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesion. Neuroscience 1998; 82: 7-19.
18. Salton SR, Ferri GL, Hahm S, et al. VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front Neuroendocrinol 2000; 21: 199-219.
19. Rindi G, Licini L, Necchi V, et al. Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia. J Clin Endocrinol Metab 2007; 92: 2811-5.
20. Huang JT, Leweke FM, Oxley D, et al. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 2006; 3: e428.